Covaxin well tolerated in those not yet vaccinated in US: Study
"Phase II/III observer-blind, immuno-bridging and broadening study was done to generate a broader immune response against the whole virus covering important antigens such as S-protein, RBD, and N-protein," it said, adding that currently approved vaccines in the US target only S-protein antigen.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
